Hello, Welcome to Shine Consultant !
Summit & Event Shine Speaker Bureau Shine Advisor Shine Event Service
  • Summit & Event :
    With field research of markets and industries which is analyzed from a global strategic perspective by our professional teams, as well as hot topics which interest leadership and management, Shine Consultant provides you with one-stop platform of dialogue, practice -sharing and social network!
  • Shine Speaker Bureau:
    Committed to provide keynote speakers, executive learning masterclasses and boardroom advisory for global enterprises and institutions, each service provides a deeper and more interactive experience, especially for small, selected audiences and key individuals. We have the resources of the most influential business leaders and experts, who are the most outstanding representatives in their fields. Our team consists of experienced speech and event managers, and we focus on building long-term and in-depth partnerships.
  • Shine Advisor:
    As world-class insight network, we connects clients-decision makers with vetted subject matter experts-advisors. Our clients leverage the insights and perspectives shared by our advisors to stay informed and make better business decisions.We have over 600,000 Shine Advisors in 20 industries, which continues to grow every day.
  • Shine Event Service:
    Committed to be the world's most professional provider of industrial Summit & Event. We provide one-stop professional services, including investigating and planning, on-demand inviting, marketing and promoting, operating, project management, live& digital conference, each service is performed by an experienced professional team matched with long-term industrial resources. We focus on establishing long-term and in-depth partnerships.
Guest Information
Bin SHI
Bin SHI
Positions:

Chief Strategy Officer

Company:

Deuracor Therapeutics, Inc.

Dr. Bin Shi (石斌)joins a startup in August 2018 serving as VP and Chief Strategy Officer for Biology and Business Development functional areas. Previously, Bin worked for Amgen, serving as Head of External R&D and Licensing of Amgen Asia R&D Center (2016 - 2018) to leverage wide external scientific and technology expertise in China and Asian Pacific areas to advance and complement Amgen’s global internal effort in discovery of breakthrough medicines. Before that, Bin worked in Merck and Schering-Plough (1998-2016), overseeing anti-cancer, anti-viral, neuroscience, and vaccine drug discovery and development. Bin has published more than 40 papers, abstracts and patents in reputed journals including JBC, Cancer Research etc, serving as the first and corresponding author, serving as an invited reviewer for eight peer reviewed journals, editorial board member and an invited speaker and meeting chairman at several conferences. She is an invited Industry Mentor by ShanghaiTech Univ. and Nankai Univ. Bin is a lifetime SAPA member, and served as President (2016-2017) in SAPA-GP; a member of BayHelix; an active member of AACR. Bin completed her Ph.D. at Thomas Jefferson University in Philadelphia, her Master of Science degree at State University of New York (SUNY) in Syracuse, and her Bachelor of Science degree at Nankai University in Tianjin China.